Singapore markets closed

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
770,000.00-10,000.00 (-1.28%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,694,588,767
3,694,588,767
3,001,295,198
1,568,006,928
1,164,776,874
Cost of revenue
1,891,824,206
1,891,824,206
1,532,847,165
841,555,563
748,700,763
Gross profit
1,802,764,561
1,802,764,561
1,468,448,033
726,451,365
416,076,110
Operating expenses
Research development
81,587,988
81,587,988
45,883,747
954,219
5,105,829
Selling general and administrative
303,534,451
303,534,451
209,490,087
102,055,300
62,866,304
Total operating expenses
689,084,552
689,084,552
484,820,638
189,141,957
123,289,556
Operating income or loss
1,113,680,009
1,113,680,009
983,627,395
537,309,408
292,786,554
Interest expense
81,596,401
81,596,401
64,064,346
14,707,182
16,085,623
Income before tax
1,119,986,931
1,119,986,931
1,009,024,574
561,282,597
265,992,163
Income tax expense
262,295,633
262,295,633
210,968,364
167,693,130
25,017,363
Income from continuing operations
857,691,298
857,691,298
798,056,210
393,589,468
240,974,800
Net income
857,691,298
857,691,298
798,056,210
393,589,468
240,974,800
Net income available to common shareholders
857,691,298
857,691,298
798,056,210
393,589,468
240,974,800
Basic EPS
13.23k
-
11.44k
5.89k
3.60k
Diluted EPS
13.22k
-
11.43k
5.89k
3.60k
Basic average shares
71,176
-
69,748
66,863
66,868
Diluted average shares
71,180
-
69,809
66,863
66,868